Search
for
Sort by
Research 91–120 of 1000+
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Impact of the COVID‐19 pandemic on inpatient dermatology: a multicentre study from Hubei, China
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- GWASs Identify Genetic Loci Associated with Human Scalp Hair Whorl Direction
- The color of skin: white diseases of the skin, nails, and mucosa
- Norman Orentreich, The Father of Hair Transplantation
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Strengthening the cellular function of dermal fibroblasts and dermal papilla cells using nanovesicles extracted from stem cells using blue light-based photobiomodulation technology
- Diagnosis and treatments of hirsutism: where are we?
- The COVID-19 pandemic and its skin effects
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Topoisomerase‐Interacting Agents
- The hidden burden of visibility: Social appearance anxiety in patients with alopecia areata – A comparative cross-sectional study
- Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China
- Evaluation of Clinical and Oral Findings in Patients with Epidermolysis bullosa
- Comment on “CCN1 secreted by human adipose‐derived stem cells enhances wound healing and promotes angiogenesis through activating the AKT signalling pathway”
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- TeSe nanoparticle-Integrated Exosomes for Accelerated Diabetic Pressure Ulcer Healing via NIR-II Triggered Synergy
- Patterns of Sensitization and Cross-Reactivity in Hair Dye Allergy: An 18-Year Tertiary-Center Experience from Greece.
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Alopecia Areata and Its Association With Anxiety and Depression: A Case–Control Study in Patients Referred to Dermatology Clinics
- Evaluation of Quality of Life, Anxiety and Depression in Patients with Alopecia Areata: A Prospective Case-Control Study
- 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries